12 Monthly Surveillance Audit by DNV

13th January 2011, Maverick Biosciences Limited and Maverick Biosciences (NZ) Limited today received a surveillance audit by Det Norske Veritas.

There were no ‘Non Conformities’ found in either minor or major categories, 1 observation was noted. The Quality Management system was found to be in satisfactory order and continued to meet the specifications of the certifying body.

The organizations Quality Manager is currently reviewing the needs of ISO13485:2003. for consideration as we continue to invest in enhancing Mavericks capabilities to meet and exceed clients needs.

PRESS RELEASES

Maverick Biomaterials Recommended for 13485 Certification

Dec 22, 2011

Maverick Biomaterials Pty Ltd, producer of cross linked GBR1 bovine pericardium in Australia and New Zealand, was audited on 23rd November by BSi for ISO 13485 Certification. This certification will optimise Maverick Biomaterials production and export of cross linked...

Maverick Biomaterials Progressing towards 13485 Certification.

Oct 18, 2011

Maverick Biomaterials is making solid progress towards probable attainment of ISO 13485 certification for Q1 2012. A Notify body audit will be completed late in the year with Mavericks Quality Manager quietly confident of a successful outcome. This will be well...

ISO.9001:2008 Certification

Jan 11, 2010

11th January 2010. Maverick Biosciences Pty Limited and Maverick Biosciences (NZ) Limited was today awarded ISO.9001:2008 certification by Det Norske Veritas, valid until 2013. It has been a very pleasing outcome in that our  investment in a Quality Management...

Supremely customised pericardium production trial begins

Jun 10, 2009

In June 2009 Maverick commenced a 3 month trial production of pericardium against very tightly defined specifications, targeting achievement of a significant increase in the overall yields experienced by our manufacturing client. Mavericks remote production team has...

PRODUCT CATEGORIES